The biology, medical management, and podiatric implications of menopause

Journal of the American Podiatric Medical Association

Volumn 92, Issue 8, 2002, Pages 437-443

  Friedlander, Arthur H ^a   Jones, Lester J ^a  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; ESTROGEN THERAPY; FEMALE; FOOT INJURY; FRACTURE; HUMAN; MENOPAUSE; MIDDLE AGED; PHYSIOLOGY; PODIATRY; POSTMENOPAUSE OSTEOPOROSIS;

CARDIOVASCULAR DISEASES; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOOT INJURIES; FRACTURES, BONE; HUMANS; MENOPAUSE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PODIATRY;

EID: 0036727977     PISSN: 87507315     EISSN: None     Source Type: Journal    
DOI: 10.7547/87507315-92-8-437     Document Type: Article

References (67)

1. BUCHAN W: Domestic Medicine: A Treatise on the Prevention and Cure of Disease by Regimen and Simple Medicines, p 1, Strahan, London, 1794.
2. SHOWALTER E: The Female Malady: Women, Madness, and English Culture, 1830-1080, p 1, Virago, London, 1987.
3. MCPHERSON A, WALLER D (EDS): Women's Health, 4th Ed, p 1, Oxford University Press, Oxford, 1997.
4. CAMERON ST, CRITCHLEY HO, GLASIER AF, ET AL: Continuous transdermal estrogen and interrupted progestin as a novel bleed-free regimen of hormone replacement therapy for postmenopausal women. Br J Obstet Gynaecol 104: 1184, 1997.
5. HARDY R, KUH D: Reproductive characteristics and the age at inception of the perimenopause in a British National Cohort. Am J Epidemiol 149: 612, 1999.
6. KHAW KT: Epidemiology of the menopause. Br Med Bull 48: 249, 1992.
7. CRESSWELL JL, EGGER P, FALL CH, ET AL: Is the age of menopause determined in-utero? Early Hum Dev 49: 143, 1997.
8. HUNTER M: The south-east England longitudinal study of the climacteric and postmenopause. Maturitas 14: 117, 1992.
9. HUNTER MS, LIAO KL: A psychological analysis of menopausal hot flushes. Br J Psychol 34 (pt 4): 589, 1995.
10. KLEIN P, VERSI E, HERZOG A: Mood and the menopause. Br J Obstet Gynaecol 106: 1, 1999.
11. CHENOY R, HUSSAIN S, TAYOB Y, ET AL: Effect of oral gamolenic acid from evening primrose oil on menopause flushing. BMJ 308: 501, 1994.
12. DALY E, GRAY A, BARLOW D, ET AL: Measuring the impact of menopausal symptoms on quality of life. BMJ 307: 836, 1993.
13. STUDD JW, WATSON NR, MONTGOMERY J: Depression and the menopause. BMJ 300: 1653, 1990.
14. PORTER M, PENNEY GC, RUSSELL D, ET AL: A population based survey of women's experience of the menopause. Br J Obstet Gynaecol 103: 1025, 1996.
15. GREENDALE GA, LEE NP, ARRIOLA ER: The menopause. Lancet 353: 571, 1999.
16. OFFICE FOR NATIONAL STATISTICS: Mortality Statistics: Cause 1993 (revised) and 1994, DH2 no 21, Her Majesty's Stationery Office, London, 1996.
17. VAN DER SCHOUW YT, VAN DER GRAAF Y, STEYERBERG EW, ET AL: Age at menopause as a risk factor for cardiovascular mortality. Lancet 347: 714, 1996.
18. STEVENSON JC: Metabolic effects of the menopause and estrogen replacement. Baillieres Clin Obstet Gynaecol 10: 449, 1996.
19. JOHNELL O: Prevention of fractures in the elderly: a review. Acta Orthop Scand 66: 90, 1995.
20. ETTINGER B, PRESSMAN A, SKLARIN P, ET AL: Associations between low levels of serum cholesterol, bone density, and fractures among elderly women: the study of osteoporotic fractures. J Clin Endocrinol Metab 83: 2239, 1998.
21. TUCCI JR: Osteoporosis update. Med Health RI 81: 169, 1998.
22. MORSE CA, SMITH A, DENNERSTEIN L, ET AL: The treatment-seeking woman at menopause. Maturitas 18: 61, 1994.
23. DEMPSTER DW, LINDSAY R: Pathogenesis of osteoporosis. Lancet 341: 797, 1993.
24. RICKARD DJ, SUBRAMANIAM M, SPELSBERG TC: Molecular and cellular mechanisms of estrogen action on the skeleton. J Cell Biochem 32/33 (suppl): 123, 1999.
25. TAKAHASHI M, KUSHIDA K, HOSHINO H, ET AL: Biochemical markers of bone turnover do not decline after menopause in healthy women. Br J Obstet Gynaecol 106: 427, 1999.
26. CUMMINGS SR, NEVITT MC, BROWNER WS, ET AL: Risk factors for hip fractures in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332: 767, 1995.
27. KANIS JA, MCCLOSKEY EV: Risk factors in osteoporosis. Maturitas 30: 229, 1998.
28. FREEMAN D, RANDALL DB: Stress fracture of the foot secondary to osteoporosis: an atypical presentation. JAPMA 91: 99, 2001.
29. SPECTOR TD, KEEN RW, ARDEN NK, ET AL: Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain. BMJ 310: 1357, 1995.
30. COOPER C, ATKINSON EJ, JACOBSEN SJ, ET AL: Population-based study of survival after osteoporotic fractures. Am J Epidemiol 137: 1001, 1993.
31. SEELEY DG, BROWNER WS, NEVITT MC, ET AL: Which fractures are associated with low appendicular bone mass in elderly women? Ann Intern Med 115: 837, 1991.
32. VARENNA M, BINELLI L, ZUCCHI F, ET AL: Is the metatarsal fracture in postmenopausal women an osteoporotic fracture? A cross-sectional study on 113 cases. Osteoporos Int 7: 558, 1997.
33. HONKANEN R, TUPPURAINEN M, KRÖGER H, ET AL: Relationships between risk factors and fractures differ by type of fracture: a population-based study of 12,192 perimenopausal women. Osteoporos Int 8: 25, 1998.
34. KRÖGER H, HUOPIO J, HONKANEN R, ET AL: Prediction of fracture risk using axial bone mineral density in a perimenopausal population: a prospective study. J Bone Miner Res 10: 302, 1995.
35. NGUYEN T, SAMBROOK P, KELLY P, ET AL: Prediction of osteoporotic fractures by postural instability and bone density. BMJ 307: 1111, 1993.
36. KAYE RA: Insufficiency stress fractures of the foot and ankle in postmenopausal women. Foot Ankle Int 19: 221, 1998.
37. SANTI M, SARTORIS DJ: Diagnostic imaging approach to stress fractures of the foot. J Foot Surg 30: 90, 1991.
38. RESNICK D, GEORGEN TG, NIWAYAMA G: "Physical Injury: Concepts and Terminology," in Diagnosis of Bone and Joint Disorders, 3rd Ed, ed by D Resnick, p 2561, WB Saunders, Philadelphia, 1995.
39. TOMEZAK RL, VAN COURT R: Metatarsal insufficiency fractures in previously underdiagnosed osteoporosis patients. J Foot Ankle Surg 39: 174, 2000.
40. LICHNIAK JE: The heel in systemic disease. Clin Podiatr Med Surg 7: 225, 1990.
41. CHRISTMAN RA: A systematic approach for radiographically evaluating joint disease in the foot. JAPMA 81: 174, 1991.
42. AGGARWAL ND, SINGH GD, AGGARWAL R, ET AL: A survey of osteoporosis using the calcaneum as an index. Int Orthop 10: 147, 1986.
43. ETTINGER B, FRIEDMAN GD, BUSH T, ET AL: Reduced mortality associated with long-term menopausal estrogen therapy. Obstet Gynecol 87: 6, 1996.
44. HUNT V, VESSEY M, MCPHERSON K: Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynaecol 97: 1080, 1990.
45. BRITISH MEDICAL ASSOCIATION AND ROYAL PHARMACEUTICAL SOCIETY OF GREAT BRITAIN: British National Formulary, 40th Ed, p 337, BMA and The Pharmaceutical Press, London, 2000.
46. CUTSON TM, MEULEMAN E: Managing menopause. Am Fam Physician 61: 1391, 2000.
47. COLLABORATIVE GROUP ON HORMONAL FACTORS IN BREAST CANCER: Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350: 1047, 1997.
48. STALLARD S, LITHERLAND JC, CORDINER CM, ET AL: Effect of hormone replacement therapy on the pathological stage of breast cancer: population based, cross sectional study. BMJ 320: 348, 2000.
49. VOIGHT LF, WEISS NS, CHU J, ET AL: Progestagen supplementation of exogenous estrogens and risk of endometrial cancer. Lancet 338: 274, 1991.
50. CAMERON IT, FRASER IS, SMITH SK: Clinical Disorders of the Endometrium and Menstrual Cycle, p 1, Oxford University Press, Oxford, 1997.
51. DELMAS PD, BJARNASON NH, MITLAK BH, ET AL: Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 337: 1641, 1997.
52. PLOUFFE L JR: Selective estrogen receptor modulators (SERMs) in clinical practice. J Soc Gynecol Investig 7 (suppl 1): S38, 2000.
53. BRYANT HU, DERE WH: Selective estrogen modulators: an alternative to hormone replacement therapy. Proc Soc Exp Biol Med 217: 45, 1998.
54. DELMAS PD: Clinical use of selective estrogen receptor modulators. Bone 25: 115, 1999.
55. ULRICH LG, BARLOW DH, STURDEE DW, ET AL: Quality of life and patient preference for sequential versus continuous combined hormone replacement therapy: the US Kliofem multicenter study experience. Int J Gynaecol Obstet 59 (suppl 1): S11, 1997.
56. GENAZZANI AR, SPINETTI A, GALLO R, ET AL: Menopause and the central nervous system: intervention options. Maturitas 31: 103, 1999.
57. MEDICAL RESEARCH COUNCIL'S GENERAL PRACTICE RESEARCH FRAMEWORK: Randomized comparison of estrogen versus estrogen plus progestin hormone replacement therapy in women with hysterectomy. BMJ 312: 473, 1996.
58. MIJATOVIC V, KENEMANS P, NETELENBOS JC, ET AL: Oral 17 beta-estradiol continuously combined with dydrogesterone lowers serum lipoprotein(a) concentrations in healthy postmenopausal women. J Clin Endocrinol Metab 82: 3543, 1997.
59. HERRINGTON DM, REBOUSSIN DM, BROSNIHAN KB, ET AL: Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 343: 522, 2000.
60. HULLEY S, GRADY D, BUSH T, ET AL: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280: 605, 1998.
61. WRITING GROUP FOR THE WOMEN'S HEALTH INITIATIVE INVESTIGATORS: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288: 321, 2002.
62. FOGELMAN I: The effects of estrogen deficiency on the skeleton and its prevention. Br J Obstet Gynaecol 103 (suppl 14): 5, 1996.
63. MICHAELSSON K, BARON JA, FARAHMAND BY, ET AL: Hormone replacement therapy and risk of hip fracture: population based case-control study. BMJ 316: 1858, 1998.
64. RIZZOLI R, BONJOUR JP: Hormones and bones. Lancet 349 (suppl 1): 20, 1997.
65. DEVINE A, DICK IM, HEAL SJ, ET AL: A four year follow-up study of the effects of calcium supplementation on bone density in elderly postmenopausal women. Osteoporos Int 7: 23, 1997.
66. LINDSAY R: The menopause and osteoporosis. Obstet Gynecol 87 (suppl 2): 16S, 1996.
67. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin intervention (PEPI) Trial. JAMA 276: 1389, 1996.